【摘 要】 目的:在对HBsAg疫苗进行长期毒性试验时,连续给予超高剂量基因重组的HBsAg疫苗后,在检测其安全性的同时观察小鼠产生IgG及其亚类抗-HBs的动态。方法:给药剂量为600μg/kg(约为人临床拟用量的600倍),每天给药一次,连续21天,末次免疫后一个月,用ELISA法检测小鼠血清中IgG及亚类(IgG1、IgG2a)抗HBs抗体。结果:超高剂量HBsAg疫苗仍可刺激机体在3周和7周产生高水平IgG和IgG1类抗-HBs,但IgG2a类抗-HBs出现较迟,在免疫3周后未曾检出,到末次接种一月后方可测出,且水平较低。结论:超高剂量乙肝疫苗对机体免疫系统无毒性作用,早期可刺激机体产生高水平IgG1类特异性抗体,后期出现与细胞免疫相关的(IgG2a)类特异性抗体,其抗体产生的规律与高剂量(60μg/kg)疫苗基本一致。

    【关键词】 乙肝HBsAg疫苗 抗-HBs-IgG IgG1 IgG2a

    Effect of Superhigh Dose hepatitis B surface antigen Vaccine on the specific antibody induced in mice

    Liu Guangze,et al

    【Abstract】 Objective:To study the safe and the specific immune responses of anti-HBs-IgG and subclass in mice, after serial Vaccted superhigh dosage of hepatitis B surface antigen.Methods:NIH mice were treated with 600μg.Kg-1.d-1 by hypodermic injection for 21d, then one monthlyconvalesent term. Anti-HBs-IgG and its subclass(IgG1、IgG2a) in mice serawere dectected by ELISA.Results:The superhigh dosage of hepatitis B surface antigen Vaccine still excited body product high levels of anti-HBs-IgG and Its IgG1 in 3th week and convalesent phase, but low levels of IgG2a Could not be deteeted untill Convalesent phase.Conclusion:The results shows that the superhigh dosage of hepatitis B surface antigen Vaccine is safe, may induced high leve specific IgG in 3th week and cell immunity in 8th week, the same with the high dosage Vaccine. ...... 濡傛灉鎮ㄥ湪浣跨敤鎵嬫満绛夋祦瑙堟椂鏃犳硶鏌ョ湅鎴栦笅杞藉叏鏂囷紝鍙兘鏄鎼滅储寮曟搸澶辩湡鈥滆浆鐮佲€濓紝璇风偣鍑诲睆骞曟渶涓嬫柟鐨勨€滅數鑴戠増鈥濇垨鈥滃師缃戦〉鈥濊闂€�


闄愪簬鏈嶅姟鍣ㄥ帇鍔涳紝缃戠珯閮ㄥ垎淇℃伅鍙緵鐖卞績浼氬憳鎴栨湁涓€瀹氱Н鍒嗙殑娉ㄥ唽浼氬憳娴佽銆�
姝�淇℃伅闇€瑕� 2 绉垎锛堝厤璐规敞鍐岀櫥褰曞悗姣忓ぉ鍙互棰嗗彇10涓Н鍒�锛夈€�
    淇℃伅浠呬緵鍙傝€冿紝涓嶆瀯鎴愪换浣曚箣寤鸿銆佹帹鑽愭垨鎸囧紩銆傛枃绔犵増鏉冨睘浜庡師钁椾綔鏉冧汉锛岃嫢鎮ㄨ涓烘鏂囦笉瀹滆鏀跺綍渚涘ぇ瀹跺厤璐归槄璇伙紝璇烽偖浠舵垨鐢佃瘽閫氱煡鎴戜滑锛屾垜浠敹鍒伴€氱煡鍚庯紝浼氱珛鍗冲皢鎮ㄧ殑浣滃搧浠庢湰缃戠珯鍒犻櫎銆�

寰俊鏂囩珷  鍏虫敞鐧炬媷  璇勮鍑犲彞  鎼滅储鏇村